Background - Statins lower cholesterol by inhibiting HMG-CoA reductase, the rate-limiting enzyme of the metabolic pathway that produces cholesterol and other isoprenoids. Little is known about their effects on metabolite and lipoprotein subclass profiles. We, therefore, investigated the molecular changes associated with pravastatin treatment compared with placebo administration using a nuclear magnetic resonance-based metabolomics platform. Methods and Results - We performed metabolic profiling of 231 lipoprotein and metabolite measures in the PREVEND IT (Prevention of Renal and Vascular End-stage Disease Intervention Trial) study, a placebo-controlled randomized clinical trial designed to test the effects of pravastatin (40 mg once daily) ...
Cholesterol homeostasis, defined as the balance between absorption and synthesis, influences circula...
Background. - In West of Scotland Coronary Prevention Study (WOSCOPS), development of type 2 diabete...
AIMS: Fibrates or nicotinic acid are usually recommended for secondary prevention of coronary heart ...
Background - Statins lower cholesterol by inhibiting HMG-CoA reductase, the rate-limiting enzyme of ...
Background: Statins lower cholesterol by inhibiting HMG-CoA reductase, the rate-limiting enzyme of t...
Background: Statins lower cholesterol by inhibiting HMG-CoA reductase, the rate-limiting enzyme of t...
BACKGROUND. Statins have pleiotropic effects on lipid metabolism. The relationship between these eff...
AbstractBackgroundStatins are first-line therapy for cardiovascular disease prevention, but their sy...
Background: Both statins and PCSK9 inhibitors lower blood low-density lipoprotein cholesterol (LDL-C...
Background Both statins and PCSK9 inhibitors lower blood low-density lipoprotein cholesterol (LDL C)...
Aims Microalbuminuria frequently clusters with the metabolic syndrome and may identify subjects at i...
Background - Limited data suggest that HMG-CoA reductase inhibitors (statins) reduce rates of kidney...
Aims Microalbuminuria frequently clusters with the metabolic syndrome and may identify subjects at i...
Aims Microalbuminuria frequently clusters with the metabolic syndrome and may identify subjects at i...
Hyperlipidemias, and notably hypercholesterolemia, represent important risk factors for atherosclero...
Cholesterol homeostasis, defined as the balance between absorption and synthesis, influences circula...
Background. - In West of Scotland Coronary Prevention Study (WOSCOPS), development of type 2 diabete...
AIMS: Fibrates or nicotinic acid are usually recommended for secondary prevention of coronary heart ...
Background - Statins lower cholesterol by inhibiting HMG-CoA reductase, the rate-limiting enzyme of ...
Background: Statins lower cholesterol by inhibiting HMG-CoA reductase, the rate-limiting enzyme of t...
Background: Statins lower cholesterol by inhibiting HMG-CoA reductase, the rate-limiting enzyme of t...
BACKGROUND. Statins have pleiotropic effects on lipid metabolism. The relationship between these eff...
AbstractBackgroundStatins are first-line therapy for cardiovascular disease prevention, but their sy...
Background: Both statins and PCSK9 inhibitors lower blood low-density lipoprotein cholesterol (LDL-C...
Background Both statins and PCSK9 inhibitors lower blood low-density lipoprotein cholesterol (LDL C)...
Aims Microalbuminuria frequently clusters with the metabolic syndrome and may identify subjects at i...
Background - Limited data suggest that HMG-CoA reductase inhibitors (statins) reduce rates of kidney...
Aims Microalbuminuria frequently clusters with the metabolic syndrome and may identify subjects at i...
Aims Microalbuminuria frequently clusters with the metabolic syndrome and may identify subjects at i...
Hyperlipidemias, and notably hypercholesterolemia, represent important risk factors for atherosclero...
Cholesterol homeostasis, defined as the balance between absorption and synthesis, influences circula...
Background. - In West of Scotland Coronary Prevention Study (WOSCOPS), development of type 2 diabete...
AIMS: Fibrates or nicotinic acid are usually recommended for secondary prevention of coronary heart ...